Invivoscribe gets Japanese nod for mutation assay as CDx for Daiichi Sankyo’s Quizartinib
Image: Invivoscribe headquarters in San Diego, California. Photo: courtesy of Business Wire.
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X